Akselbrad Dikla Czaczkes
Transaction: 07/15/2026
BUY
Change
+149,000
Price
$4.46
Filing
07/17/2026
Type
BUY
PolyPid Ltd.
PYPD • Biotechnology
$5.39
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$122.02M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.25Healthy liquidity · 1.97Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:01 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.39
Change0.00%
Shares Out22.64M
Market Cap$122.02M
Enterprise Value$115.45M
52W Range3.06 - 5.73
Beta1.40
P/E-3.87
P/B22.65
EV/EBITDA-3.75
Earnings Yield-25.82%
FCF Yield0.00%
Price$5.39
Change0.00%
Shares Out22.64M
Market Cap$122.02M
Enterprise Value$115.45M
52W Range3.06 - 5.73
Beta1.40
P/E-3.87
P/B22.65
EV/EBITDA-3.75
Earnings Yield-25.82%
FCF Yield0.00%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.25
Current Ratio1.97
Quick Ratio1.82
Target$12.50
Target Upside131.91%
Target Median$12.50
Target Range12.00 - 13.00
Volume121.22K
Avg Volume169.93K
EPS Surprise0.12
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score▼
Manageable debt level · 0.25Healthy liquidity · 1.97Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
94/100
Bullish
Bullish
8
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$12.00
Mean
$12.50
Median
$12.50
High
$13.00
Insider Transactions
Recent executive and insider activity
Story Brooke
Transaction: 07/15/2026
BUY
Change
+9,132
Price
$4.46
Filing
07/17/2026
Type
BUY
Krinsky Itzhak
Transaction: 07/15/2026
BUY
Change
+9,132
Price
$4.46
Filing
07/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Akselbrad Dikla Czaczkes | BUY | +149,000 | $4.46 | 07/15/2026 | 07/17/2026 |
| Story Brooke | BUY | +9,132 | $4.46 | 07/15/2026 | 07/17/2026 |
| Krinsky Itzhak | BUY | +9,132 | $4.46 | 07/15/2026 | 07/17/2026 |
| BenAmram Joseph | BUY | +9,132 | $4.46 | 07/15/2026 | 07/17/2026 |
| Dror-Darwish Nir | BUY | +9,132 | $4.46 | 07/15/2026 | 07/17/2026 |
| Stein Robert Benjamin | BUY | +9,132 | $4.46 | 07/15/2026 | 07/17/2026 |
| Barenholz Yechezkel | BUY | +9,132 | $4.46 | 07/15/2026 | 07/17/2026 |
| Hazan Dalit Fellous | BUY | +75,000 | $4.46 | 05/11/2026 | 07/17/2026 |
| Missulawin Jonathan | BUY | +49,000 | $4.46 | 05/11/2026 | 07/17/2026 |
| Warshavsky Ori | BUY | +46,000 | $4.46 | 05/11/2026 | 07/17/2026 |
| Jacobovitz Yitzchak Shlomo | OTHER | 0 | Not reported | 03/18/2026 | 04/06/2026 |
| Stein Robert Benjamin | OTHER | +14,440 | $2.67 | 08/12/2025 | 04/06/2026 |
| Stein Robert Benjamin | OTHER | +6,500 | $4.24 | 10/02/2024 | 04/06/2026 |
| Stein Robert Benjamin | OTHER | +312 | $11.40 | 08/05/2023 | 04/06/2026 |
| Stein Robert Benjamin | OTHER | +312 | $23.07 | 08/03/2022 | 04/06/2026 |
| Warshavsky Ori | OTHER | 0 | Not reported | 03/18/2026 | 03/26/2026 |
| Dror-Darwish Nir | OTHER | +14,440 | $2.67 | 08/12/2025 | 03/26/2026 |
| Warshavsky Ori | OTHER | +25,200 | $2.67 | 06/09/2025 | 03/26/2026 |
| Dror-Darwish Nir | OTHER | +6,500 | $4.24 | 10/02/2024 | 03/26/2026 |
| Warshavsky Ori | OTHER | +7,667 | $11.01 | 08/07/2024 | 03/26/2026 |